期刊文献+

骨桥蛋白OPN和黏附分子CD44v6在肺癌中的表达 被引量:6

Expression and clinicopathological significance of OPN and CD44v6 in lung cancer
下载PDF
导出
摘要 背景与目的近年来关于细胞表面黏附分子(CD44)与肺癌关系的相关研究较多,而对骨桥蛋白(OPN)的研究还不太多。本研究旨在探讨OPN和CD44v6在肺癌中的表达水平及其相互关系。方法应用免疫组织化学方法对78例肺癌组织标本进行OPN和CD44v6检测。结果65例非小细胞肺癌中OPN和CD44v6阳性表达率分别为58.46%、66.15%,13例小细胞肺癌中OPN和CD44v6表达均为阴性(P<0.01)。OPN和CD44v6阳性表达率与患者TNM分期有密切关系(P<0.01),而与细胞分化程度无明显关系(P>0.05)。OPN和CD44v6在肺癌中的表达呈正相关(r=0.255,P<0.05)。结论OPN和CD44v6的表达同肺癌病理类型和分期有密切关系,二者在肺癌转移中可能起协同作用,有望作为临床评估非小细胞肺癌进展及预测肿瘤转移潜能的指标。 Background and objective There have been a lot of studies about surface adhesion molecule (CD44) in recent years, however study on osteopontin (OPN) is still few. The aim of this study is to investigate the levels of OPN and CD44v6 in lung cancer and their correlation. Methods OPN and CD44v6 expression were detected in 78 lung cancer tissues by immunohistochemistry. Results The positive rate of OPN and CD44v6 expression in non-small cell lung cancer (NSCLC) was 58.46% and 66.15% respectively, but no positive case in small cell lung cancer. The expression of OPN and CD44v6 in NSCLC was closely related to TNM stages (P〈0.01), but not to cell differentiation (P〉0.05). There was a remarkably positive correlation between the expression of OPN and CD44v6 (r= 0. 255, P〈0.05). Conclusion The co-expression of OPN and CD44v6 may be involved in progression and metastasis of lung cancer. The interrelationship of OPN and CD44v6 was coordinative with development and metastasis of lung cancer. It might be helpful to predict the metastasis and prognosis of NSCLC.
出处 《中国肺癌杂志》 CAS 2007年第2期98-101,共4页 Chinese Journal of Lung Cancer
关键词 肺肿瘤 免疫组化 骨桥蛋白OPN 黏附分子CD44V6 Lung neoplasms Immunohistochemistry OPN CD44v6
  • 相关文献

参考文献12

  • 1Shijubo N,Uede T,Kon S,et al.Vascular endothelial growth factor and osteopontin in stage Ⅰ lung adenoeareinoma.Am J Respir Crit Care Med,1999,160(4):1269-1273.
  • 2Zhang J,Takahashi K,Takahashi F,et al.Differential osteopontin expression in lung cancer.Cancer Lett,2001,171(2):215-222.
  • 3左万里,李海刚.非小细胞肺癌组织中CD44v6和Paxillin的表达及其与预后的关系[J].四川大学学报(医学版),2003,34(3):484-485. 被引量:13
  • 4王辅林,韦立新.CD44v6在肺癌组织的表达[J].中国医学科学院学报,2001,23(4):401-402. 被引量:5
  • 5喻钧,潘铁成,李军,魏翔,陈涛,胡敏,宋定伟,刘立刚,陈鹏.OPN、CD44v6及MMP-2在肺鳞癌、腺癌中的表达及其临床意义[J].中国肺癌杂志,2006,9(4):325-328. 被引量:15
  • 6Kondo K,Miyoshi T,Hino N,et al.High frequency expressions of CD44 standard and variant forms in non-small cell lung cancers,but not in small cell lung cancers.J Surg Oncol,1998,69(3):128-136.
  • 7Nguyen VN,Mirejovsky T,Melinova L,et al.CD44 and its v6spliced variant in lung carcinomas:relation to NCAM,CEA,EMA and UP1 and prognostic significance.Neoplasma,2000,47 (6):400-408.
  • 8Shimbori M,Kijima H,Sato S,et al.Expression of CD44 in primary lung carcinomas using histological and cytological analyses.Anticancer Res,2003,23(1A):115-121.
  • 9李永怀,桂淑玉,周青,胡向阳,吴强,汪渊.肺癌骨桥蛋白和CD44v6的表达与转移关系的研究[J].肿瘤,2006,26(1):55-58. 被引量:10
  • 10Fedarko NS,Jain A,Karadag A,et al.Elevated serum bone sialoprotein and osteopontin in colon,breast,prostate,and lung cancer.Clin Cancer Res,2001,7(12):4060-4066.

二级参考文献41

  • 1罗锦辉,唐建武.PDGF-B、PDGFR-α在小细胞肺癌中的不同表达[J].肿瘤,2004,24(5):476-477. 被引量:12
  • 2林全,王良兴.骨桥蛋白与血管重塑的关系研究进展[J].医学综述,2004,10(12):731-733. 被引量:8
  • 3PARKIN D M,BRAY F,FERLAY J,et al.Global cancer statistics,2002[J].CA-Cancer J Clin,2005,55(2):74-108.
  • 4SCHNEIDER S,YOCHIM J,BRABENDER J,et al.Osteopontin but not osteonectin messenger RNA expression is a prognostic marker in curatively resected non-small cell lung cancer[J].Clin Cancer Res,2004,10(5):1588-1596.
  • 5MIYOSHI T,KONDO K,HINO N,et al.The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer[J].Clin Cancer Res,1997,3(8):1289-1297.
  • 6SHIJUBO N,UEDE T,KON S,et al.Vascular endothelial growth factor and osteopontin in stage 1 lung adenocarcinoma[J].Am J Respir Crit Care Med,1999,160:1269-1273.
  • 7BROWN L F,PAPADOPOULOS S A,BERSE B,et al.Osteopontin expression and distribution in human carcinomas[J].Am J Pathol,1994,145:610-623.
  • 8ZHANG J,TAKAHASHI K,TAKAHASHI F,et al.Differential osteopontin expression in lung cancer[J].Cancer Let,2001,171:215-222.
  • 9AGRAWAL D,CHEN T,IRBY R,et al.Osteopontin identified as lead marker of colon cancer progression,using pooled sample expression profiling[J].J Natl Cancer Inst,2002,94:513-521.
  • 10DENHARDT DT,GIACHELLI C M,RITTLING SR.Role of osteopontin in cellular signaling and toxicant injury[J].Annu Rev Pharmacol Toxicol,2001,41:723-749.

共引文献37

同被引文献38

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部